Related Experiment Video

Updated: Jun 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Time for new indications for statins?

Maciej Banach1, Dimitri P Mikhailidis, Sverre E Kjeldsen

  • 1Department of Hypertension, Medical University of Łódź, Łódź, Poland. maciejbanach@aol.co.uk

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|December 1, 2009
PubMed

Insights

Statins are proven for cardiovascular disease prevention but their role in heart failure, hypertension, and chronic kidney disease (CKD) needs more research. Large clinical trials are required to confirm benefits in these patient groups.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Nephrology

Background:

  • Statins are widely recognized for treating and preventing cardiovascular diseases like coronary artery disease, acute coronary syndromes, diabetes, and stroke.
  • Uncertainty remains regarding statin efficacy in specific patient populations, including those with heart failure, hypertension, atrial fibrillation, and chronic kidney disease (CKD).

Discussion:

  • This review focuses on the existing evidence for statin use in patients with hypertension, with or without dyslipidemia, and in patients with CKD.
  • The discussion highlights the ongoing debate and the need for further investigation into the benefits and risks of statins in these complex patient profiles.

Key Insights:

  • Established cardiovascular benefits of statins are well-documented for common conditions.
  • The application of statins in patients with hypertension and chronic kidney disease (CKD) requires further clarification.
  • Current evidence suggests potential benefits, but definitive conclusions are pending.

Outlook:

  • Future research should prioritize large-scale, randomized clinical trials to definitively assess statin effectiveness in patients with hypertension and CKD.
  • These trials are crucial for establishing clear guidelines and optimizing treatment strategies for these specific patient groups.
  • The findings from such trials will help resolve current uncertainties and refine the role of statins in comprehensive cardiovascular and renal care.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...